We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $97.9B
1-Year Est. Return 20.73%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+20.73%
3 Year Est. Return
+127.31%
5 Year Est. Return
+136.48%
10 Year Est. Return
+1,577.48%
AUM
$56.8B
AUM Growth
-$682M
Cap. Flow
+$1.91B
Cap. Flow %
3.36%
Top 10 Hldgs %
48.78%
Holding
206
New
24
Increased
85
Reduced
57
Closed
9

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$1.17B
2
RACE icon
Ferrari
RACE
+$497M
3
JUNO
Juno Therapeutics, Inc.
JUNO
+$371M
4
UAA icon
Under Armour
UAA
+$348M
5
APA icon
APA Corp
APA
+$309M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$513M
2
MTB icon
M&T Bank
MTB
+$486M
3
HOG icon
Harley-Davidson
HOG
+$379M
4
ISRG icon
Intuitive Surgical
ISRG
+$364M
5
PYPL icon
PayPal
PYPL
+$345M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.5%
2 Communication Services 21.06%
3 Healthcare 12.98%
4 Financials 9.34%
5 Technology 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETSY icon
176
Etsy
ETSY
$8.2B
$4.22M 0.01%
485,000
-731,185
-60% -$5.85M
POWI icon
177
Power Integrations
POWI
$3.6B
$4.01M 0.01%
161,360
FARO
178
DELISTED
Faro Technologies
FARO
$4M 0.01%
124,080
-15,000
-11% -$419K
MCHP icon
179
Microchip Technology
MCHP
$43.8B
$3.98M 0.01%
165,320
REGN icon
180
Regeneron Pharmaceuticals
REGN
$78.3B
$3.64M 0.01%
10,100
-2,600
-20% -$1.07M
ADAP
181
DELISTED
Adaptimmune Therapeutics
ADAP
$3.49M 0.01%
+429,700
New +$3.51M
FMI
182
DELISTED
Foundation Medicine, Inc.
FMI
$3.18M 0.01%
174,800
SKM icon
183
SK Telecom
SKM
$13.4B
$3.15M 0.01%
94,919
ARMH
184
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$3.12M 0.01%
71,451
CDXS icon
185
Codexis
CDXS
$154M
$3.06M 0.01%
985,133
+120,000
+14% +$463K
KDNY
186
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.95M 0.01%
+46,000
New +$3.72M
BIOA
187
DELISTED
BioAmber Inc.
BIOA
$2.43M ﹤0.01%
579,540
RIO icon
188
Rio Tinto
RIO
$161B
$2M ﹤0.01%
70,626
SNMX
189
DELISTED
Senomyx, Inc.
SNMX
$1.5M ﹤0.01%
578,000
PCRX icon
190
Pacira BioSciences
PCRX
$1.09B
$1.46M ﹤0.01%
27,500
+1,300
+5% +$76K
FOMX
191
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.43M ﹤0.01%
219,400
ACTG icon
192
Acacia Research
ACTG
$445M
$1.39M ﹤0.01%
365,820
VALE.P
193
DELISTED
Vale S A
VALE.P
$1.01M ﹤0.01%
323,000
-33,100
-9% -$76.1K
EFA icon
194
iShares MSCI EAFE ETF
EFA
$79.3B
$621K ﹤0.01%
+10,868
New +$599K
YOKU
195
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$394K ﹤0.01%
14,343
-37,835
-73% -$1.03M
ONC
196
BeOne Medicines Ltd
ONC
$33.5B
$54K ﹤0.01%
+1,850
New +$52.4K
EHC icon
197
Encompass Health
EHC
$11B
$15K ﹤0.01%
+9,151
New +$253K
MESO
198
Mesoblast
MESO
$1.92B
-67,800
Closed -$863K
NOAH
199
Noah Holdings
NOAH
$577M
-152,950
Closed -$4.27M
BITA
200
DELISTED
Bitauto Holdings Limited
BITA
-109,990
Closed -$3.11M

Similar funds

Baillie Gifford & Co's Q1 2016 Portfolio in Review

As of Q1 2016, Baillie Gifford & Co held 206 positions worth $56.8B, down 1.2% from $57.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Baillie Gifford & Co deployed $1.91B of net new capital in Q1 2016, opening 24 new positions and adding to 85 existing holdings. Its largest new stake was TSMC: 49,857,061 shares worth $1.31B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 34% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Stellantis, an estimated $513M trimmed.

  • Baillie Gifford & Co's largest Q1 2016 buy was TSMC: 49,857,061 shares worth $1.31B.
  • Baillie Gifford & Co added most to Juno Therapeutics, Inc. in Q1 2016, an estimated $371M increase.
  • Baillie Gifford & Co's biggest Q1 2016 reduction was Stellantis, cutting an estimated $513M.
  • Baillie Gifford & Co fully exited MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2016, selling an estimated $136M.
  • Baillie Gifford & Co's ten largest holdings make up 49% of its $56.8B portfolio in Q1 2016.
  • Baillie Gifford & Co opened 24 new positions and closed 9 in Q1 2016.
  • Baillie Gifford & Co's portfolio value fell 1.2% quarter-over-quarter to $56.8B.

Based on Baillie Gifford & Co's 13F filing for Q1 2016, filed 5 May 2016.